AMEACHI LINDA AJAKWE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BURBANK, CA NPI 1992249189

General Payments — all program years on this page

$1,532.04

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 79
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $303.21 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $303.2115

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $168.388
GlaxoSmithKline, LLC. $41.862
ViiV Healthcare Company $38.472
Acerta Pharma LLC $20.291
Janssen Pharmaceuticals, Inc $19.161
Novo Nordisk AS $15.051

By program year

Program yearAmountRecords
2021 $114.576
2022 $319.3116
2023 $794.9542
2024 $303.2115

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077932689 Janssen Pharmaceuticals, Inc $19.16 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100601781 Novo Nordisk Inc $15.05 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104522252 AstraZeneca Pharmaceuticals LP $20.29 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112731631 ViiV Healthcare Company $16.89 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112817911 ViiV Healthcare Company $21.58 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116035489 GlaxoSmithKline, LLC. $16.58 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116247969 GlaxoSmithKline, LLC. $25.28 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135493570 Lilly USA, LLC $31.23 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135520963 Lilly USA, LLC $31.27 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135520965 Lilly USA, LLC $28.66 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135524761 Lilly USA, LLC $8.28 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135524763 Lilly USA, LLC $11.08 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135524765 Lilly USA, LLC $16.87 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135530060 Lilly USA, LLC $6.58 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135530065 Lilly USA, LLC $34.41 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.